Attached files
file | filename |
---|---|
8-K - MEDEFILE INTERNATIONAL, INC. FORM 8-K - Coro Global Inc. | form8k.htm |
Exhibit 99.1
MedeFile International Reports Second Quarter 2011 Results
Company Marks Fourth Consecutive Quarter of Double-Digit Revenue and Membership Growth
BOCA RATON, FL--(Marketwire -08/15/11)- MedeFile International, Inc. (OTCQB: MDFI.PK - News) (Pinksheets: MDFI.PK - News), a leader in Internet-enabled Personal Health Record (iPHR) management solutions, today announced its financial and operational results for the three and six months, ended June 30, 2011.
Financial Highlights for Three Months Ended June 30, 2011 Compared to Three Months Ended June 30, 2010:
●
|
Revenues rose to $187,740, representing a 43-fold (4325%) increase from $4,242.
|
o
|
When comparing subsequent quarter-over-quarter results, the Company posted its fourth consecutive quarter of double-digit growth, rising 42% from $132,102 reported for the three months ended March 31, 2011. (See Chart)
|
●
|
Net loss declined 50% to $663,237, or $0.00 loss per basic and diluted share, from $1,326,658, or $0.00 loss per basic and diluted share.
|
Financial Highlights for Six Months Ended June 30, 2011 Compared to Six Months Ended June 30, 2010:
●
|
Revenues totaled $319,942, climbing significantly (4745%) from $6,602.
|
●
|
Net loss was $1,111,429, or $0.00 loss per basic and diluted share, a 22% decrease from $1,417,198, or $0.00 loss per basic and diluted share.
|
As of June 30, 2011, cash totaled $311,975; there was zero long term debt; and stockholders' equity totaled $204,458.
Operational Highlights:
●
|
Total members registered on the MedeFile system was approximately 15,200 as of the end of June 30, 2011, up from approximately 7,000 as of March 31, 2011.
|
●
|
Social marketing has helped spur a notable increase in people who are following MedeFile on Facebook, with the number of "likes" now totaling over 18,800, which is up nearly 11,000 just since May 2011.
|
●
|
In an effort to support certain global growth opportunities presented to MedeFile by current strategic partners, the Company's web site and secure back-end member interface is now fully operational in English, Russian and Spanish. MedeFile's web development team is currently focused on completing translations in German and French, both of which are expected to be completed in the third quarter.
|
●
|
Last week, MedeFile announced that it will begin airing 60-second infomercials and four different six-minute interviews with the Company's Chairman, President and CEO Kevin Hauser, in an effort to promote mass market awareness of MedeFile and to educate U.S. consumers on the need for and many benefits of MedeFile's personal health record solutions. Over the year-long campaign produced by FMW Media Works (FMW), a minimum of 1,000 spots will be televised on ION and FOX cable networks and may be substituted at FMW's discretion on ABC, CBS, CNN and MSNBC in the following metro markets: New York, Los Angeles, Chicago, Dallas, Boston, Philadelphia, San Francisco/San Jose, Atlanta, Washington and Houston. Although it is not possible to forecast with any level of accuracy the impact that this sponsored ad campaign will have on MedeFile's membership growth in the coming year, management is optimistic that this marketing strategy will -- at a minimum -- help to promote strong brand integrity and awareness among American consumers, investors and major stakeholders in the global healthcare industry.
|
Commenting on other growth initiatives, Hauser noted that "In connection with numerous strategic collaborations formed with a broad range of entities over the past six months, we have continued to actively pursue discussions and negotiations with several potential new corporate, institutional and government clients to provide MedeFile Premium and MedeFile Lite subscriptions to their respective employees, customers and members via volume-driven wholesale contracts and upsell opportunities. In this regard, it is anticipated that the Company will shortly be in a position to begin announcing key new contracts that hold the potential to be real 'game changers' for MedeFile -- significantly contributing to future recurring revenue, cash flow and earnings growth," stated Hauser.
"We couldn't be more excited about the direction MedeFile is heading and remain highly confident that strategies we are executing now will ultimately culminate in MedeFile winning worldwide recognition as the leading iPRH solutions provider," concluded Hauser.
FINANCIAL CHARTS FOLLOW
MEDEFILE INTERNATIONAL, INC.
BALANCE SHEETS
Unaudited
|
||||||||
June 30,
|
December 31,
|
|||||||
Assets
|
2011
|
2010
|
||||||
Current assets
|
||||||||
Cash
|
$ | 311,975 | $ | 499,652 | ||||
Inventory
|
27,904 | 22,184 | ||||||
Merchant services reserve
|
53,267 | 6,173 | ||||||
Accounts receivable, net
|
2,810 | 2,468 | ||||||
Prepaid Insurance
|
4,494 | - | ||||||
Total current assets
|
400,450 | 530,477 | ||||||
Website development, net of accumulated amortization
|
36,718 | 47,210 | ||||||
Furniture and equipment, net of accumulated depreciation
|
15,251 | 20,364 | ||||||
Investment
|
1,800 | - | ||||||
Intangibles
|
1,339 | 1,339 | ||||||
Total assets
|
$ | 455,558 | $ | 599,390 | ||||
Liabilities and Stockholders' Equity
|
||||||||
Accounts payable and accrued liabilities
|
$ | 244,379 | $ | 310,325 | ||||
Cash overdraft
|
- | 6,928 | ||||||
Deferred revenues
|
6,721 | 9,575 | ||||||
Total Current Liabilities
|
251,100 | 326,828 | ||||||
Stockholders' Equity
|
||||||||
Preferred stock, $.0001 par value: 10,000 authorized,
|
||||||||
no shares issued and outstanding
|
- | - | ||||||
Common stock, $.0001 par value: 5,000,000,000 authorized;
|
||||||||
3,678,049,471 and 3,450,021,410 shares issued and outstanding on
|
||||||||
June 30, 2011 and December 31, 2010, respectively
|
367,805 | 345,002 | ||||||
Common stock payable
|
159,000 | - | ||||||
Additional paid in capital
|
16,951,638 | 16,090,116 | ||||||
Accumulated deficit
|
(17,273,985 | ) | (16,162,556 | ) | ||||
Total stockholders' equity
|
204,458 | 272,562 | ||||||
Total liability and stockholders' equity
|
$ | 455,558 | $ | 599,390 |
4
MEDEFILE INTERNATIONAL, INC.
STATEMENT OF OPERATIONS
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2011 AND JUNE 30, 2010
For the Three
|
For the Three
|
For the Six
|
For the Six
|
|||||||||||||
Months
|
Months
|
Months
|
Months
|
|||||||||||||
Ended
|
Ended
|
Ended
|
Ended
|
|||||||||||||
June 30,
|
June 30,
|
June 30,
|
June 30,
|
|||||||||||||
2011
|
2010
|
2011
|
2010
|
|||||||||||||
Revenue
|
$ | 187,740 | $ | 4,242 | $ | 319,842 | $ | 6,602 | ||||||||
Cost of goods sold
|
90,267 | - | 153,741 | - | ||||||||||||
Gross profit
|
97,473 | 4,242 | 166,101 | 6,602 | ||||||||||||
Operating expenses
|
||||||||||||||||
Selling, general and administrative expenses
|
442,085 | 101,135 | 821,205 | 180,309 | ||||||||||||
Maketing expense
|
310,867 | - | 440,721 | - | ||||||||||||
Depreciation and amortization expense
|
7,758 | 9,441 | 15,604 | 13,692 | ||||||||||||
Total operating expenses
|
760,710 | 110,576 | 1,277,530 | 194,001 | ||||||||||||
Loss from operations
|
(663,237 | ) | (106,334 | ) | (1,111,429 | ) | (187,399 | ) | ||||||||
Other expenses
|
||||||||||||||||
Interest expense - note payable
|
- | (3,879 | ) | - | (10,166 | ) | ||||||||||
Interest expense - related party note payable
|
- | (1,216,445 | ) | - | (1,219,633 | ) | ||||||||||
Total other expenses
|
- | (1,220,324 | ) | - | (1,229,799 | ) | ||||||||||
Loss before income tax
|
(663,237 | ) | (1,326,658 | ) | (1,111,429 | ) | (1,417,198 | ) | ||||||||
Provision for income tax
|
- | - | - | - | ||||||||||||
Net Loss
|
$ | (663,237 | ) | $ | (1,326,658 | ) | $ | (1,111,429 | ) | $ | (1,417,198 | ) | ||||
Net loss per share: basic and diluted
|
$ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | ||||
Weighted average share outstanding
|
3,584,124,074 | 1,463,021,410 | 3,517,124,825 | 1,463,021,410 | ||||||||||||
basic and diluted
|
5
About MedeFile International, Inc.
Headquartered in South Florida, MedeFile has developed and globally markets a proprietary, patient-centric, iPHR (Internet-enabled Personal Health Record) system for gathering, digitizing and organizing medical records so that individuals can have a comprehensive record of all of their medical visits. MedeFile's primary product is its web-based MedeFile solution, a highly secure system for gathering, maintaining, accessing and sharing personal medical records. Interoperable with most electronic medical record management systems marketed to the healthcare industry, the MedeFile solution is designed to gather all of its members' actual medical records and create a single, comprehensive Electronic Health Record (EHR) that is accessible 24 hours a day, seven days a week by the member and the member's authorized users on any web-enabled device (PC, cell phone, smartphone, e-reader) and portable MedeDrive unit. For more information about MedeFile and its annual subscription-based programs, please visit www.medefile.com. You can also follow the Company on Facebook!
Safe Harbor Statement Under the Private Securities Litigation Act of 1995
With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of MedeFile could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, and such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors associated with our Company, review our SEC filings.